Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
ONCY	Oncolytics Biotech Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.76M	n/a	n/a	n/a	-$0.30
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
IMMX	Immix Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.44M	n/a	-31.4%	n/a	-$0.89
CALC	CalciMedica, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.56M	n/a	n/a	n/a	-$1.97
HURA	TuHURA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$30.05M	n/a	-143.6%	n/a	-$0.63
RFL	Rafael Holdings, Inc. Manufacturing · Year ended 2025-07-31 · USD	$917.0K	-$30.52M	n/m	-31.0%	44.0%	-$1.04
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
GNLX	Genelux Corp Manufacturing · Year ended 2025-12-31 · USD	$8.0K	-$32.15M	n/m	-278.5%	0.0%	-$0.86
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
IBIO	iBio, Inc. Manufacturing · Year ended 2026-06-30 · USD	$100.0K	-$33.04M	n/m	-38.6%	-75.0%	-$0.32
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
MBRX	Moleculin Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$33.56M	n/a	-223.6%	n/a	n/a
ALDX	Aldeyra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$33.85M	n/a	-76.5%	n/a	-$0.56
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
DWTX	Dogwood Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.26M	n/a	-45.7%	n/a	-$7.13
PDSB	PDS Biotechnology Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.50M	n/a	-372.9%	n/a	-$0.74
RNAZ	Transcode Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.66M	n/a	-335.4%	n/a	-$52.59
ATOS	Atossa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.77M	n/a	-88.4%	n/a	-$4.04
XLO	Xilio Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$43.77M	-$35.04M	-80.1%	-99.3%	589.9%	-$4.19
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
CNTX	Context Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$36.12M	n/a	-59.7%	n/a	-$0.38
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
EPRX	Eupraxia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.58M	n/a	-47.0%	n/a	-$1.03
LFCR	Lifecore Biomedical, Inc. Manufacturing · Year ended 2025-05-25 · USD	$128.87M	-$38.72M	-30.0%	n/m	0.5%	-$1.27

Rows per page: 2550 100